Sequencing of whole tumor genomes holds the promise of revealing functional somatic 10 regulatory mutations, such as those described in the TERT promoter. Recurrent 11 promoter mutations have been identified in many additional genes and appear to be 12 particularly common in melanoma, but convincing functional data such as influence on 13 gene expression has been more elusive. Here, we show that frequently recurring 14 promoter mutations in melanoma occur almost exclusively at cytosines flanked by a 15 distinct sequence signature, TTCCG, with TERT as a notable exception. In active, but 16 not inactive, promoters, mutation frequencies for cytosines at the 5' end of this ETS-like 17 motif were considerably higher than expected based on a UV trinucleotide mutational 18 signature. Additional analyses solidify this pattern as an extended context-specific 19 mutational signature that mediates an exceptional position-specific vulnerability to UV 20 mutagenesis, arguing against positive selection. We further use ultra-sensitive amplicon 21 sequencing to demonstrate that cell cultures exposed to UV light quickly develop 22 subclonal mutations specifically in affected positions. Our findings have implications for 23 the interpretation of somatic mutations in regulatory regions, and underscore the 24 importance of genomic context and extended sequence patterns to accurately describe 25 mutational signatures in cancer. 26 27 28
Main text
A major challenge in cancer genomics is the separation of functional somatic driver mutations 30 from non-functional passengers. This problem is relevant not only in coding regions, but also 31 in the context of non-coding regulatory regions such as promoters, where putative driver 32 mutations are now mappable with relative ease using whole genome sequencing 1,2 . One 33 important indicator of driver function is recurrence across independent tumors, which can be 34 suggestive of positive selection. However, proper interpretation of recurrent mutations 35 requires a detailed understanding of how somatic mutations occur in the absence of selection 36
pressures. Somatic mutations are not uniformly distributed across tumor genomes, and 37 regional variations in mutation rates have been associated with differences in transcriptional 38 activity, replication timing as well as chromatin accessibility and modification [3] [4] [5] . Impaired 39 nucleotide excision repair (NER) has been shown to contribute to increased local mutation 40 density in promoter regions and protein binding sites 6, 7 . Additionally, analyses of mutational 41 processes and their sequence signatures have shown the importance of the immediate 42 sequence context for local mutation rates 8 . Still, our understanding of mutational 43 heterogeneity is incomplete, and it is not clear to what extent such effects can explain 44 recurrent somatic mutations in promoter regions, which are suggested by some studies to be 45 particularly frequent in melanoma despite several other cancer types approaching melanoma 46 in terms of total mutation load 9, 10 . 47
To characterize somatic promoter mutations in melanoma, we analyzed the sequence 48 context of recurrently mutated individual genomic positions occurring within +/-500 bp of 49 annotated transcription start sites (TSSs), based on 38 melanomas subjected to whole genome 50 sequencing by the Cancer Genome Atlas 10, 11 . Strikingly, of 17 highly recurrent promoter 51 mutations (recurring in at least 5/38 of tumors, 13%), 14 conformed to an identical 6 bp 52 sequence signature (Table 1, Fig. 1a) . Importantly, the only exceptions were the previously 53 described TERT promoter mutations at chr5:1,295,228, 1,295,242 and 1,295,250 12, 13 (Table 1 , 54 Fig. 1b) . The recurrent mutations occurred at cytosines positioned at the 5' end or one base 55 upstream of the motif CTTCCG (Fig. 1c) , and were normally C>T or CC>TT transitions 56 (Table 1) . Similar to most mutations in melanoma they were thus C>T changes in a 57 dipyrimidine context, compatible with UV-induced damage through cyclobutane pyrimidine 58 dimer (CPD) or 6-4 photoproduct formation 8, 14 . Out of 15 additional positions recurrently 59 mutated in 4/38 tumors, 13 conformed to the same pattern, while the remaining two showed 60 related sequence contexts ( Table 1) . Many less recurrent sites also showed the same pattern ( Supplementary Table 1 ). The signature described here matches the consensus binding 62 sequence of ETS family transcription factors (TFs) 15 , and the results are consistent with recent 63
reports showing that ETS promoter sites are often recurrently mutated in melanoma 9 and that 64 such mutations preferably occur at cytosines upstream of the core TTCC sequence 16 . Thus, 65 while recurrent promoter mutations are common in melanoma, they consistently adhere to a 66 distinct sequence signature, which may argue against positive selection as a major causative 67 factor. 68
The recurrently mutated positions were next investigated in additional cancer cohorts, 69 first by confirming them in an independent melanoma dataset 17 (Supplementary Table 2) . 70 We found that the identified hotspot positions were often mutated also in cutaneous squamous 71 cell carcinoma (cSCC) 18 ( Supplementary Table 3 ) as well as in sun-exposed skin 18, 19 , albeit 72 at lower variant frequencies ( Supplementary Fig. 1, Supplementary Table 4 ). Additionally, 73 one of the mutations, upstream of DPH3, was recently described as highly recurrent in basal 74 cell skin carcinoma 20 . However, we did not detect mutations in these positions in 13 non-UV-75 exposed cancer types (Supplementary Table 5 ). The hotspots are thus present in UV-76 exposed samples of diverse cellular origins, but in contrast to the TERT promoter mutations 77 they are completely absent in non-UV-exposed cancers. This further supports that recurrent 78 mutations at the 5' end of CTTCCG elements are due to elevated susceptibility to UV-79 induced mutagenesis in these positions. 80
Next, we considered additional properties that could support or argue against a 81 functional role for the recurrent mutations. We first noted a general lack of known cancer-82 related genes among the affected promoters, with TERT as one of few exceptions (Table 1  83 and Supplementary Table 1 , indicated in blue). Secondly, the recurrent promoter mutations 84 were not associated with differential expression of the nearby genes (Table 1 and 85 Supplementary Table 1 ). This is in agreement with earlier investigations of some of these 86 mutations, which gave no conclusive evidence regarding influence on gene expression 9, 16, 20 , 87 although it should be noted that significant association is lacking also for TERT in this 88 relatively small cohort 10 . Lastly, we found that when comparing different tumors there was a 89 strong positive correlation between the total number of the established hotspot positions that 90 were mutated and the genome-wide mutation load, both in melanoma ( Fig. 2a ; Spearman's r 91 = 0.88, P = 2.8e-13) and in cSCC ( Supplementary Table 3 ; r = 0.78, P = 0.026). This is 92 again compatible with a passive model involving elevated mutation probability in the affected 93 positions. Importantly, this contrasted sharply with most of the major driver mutations in 94 melanoma, which were detected also in tumors with lower mutation load ( Fig. 2b , 95 Supplementary Table 3 ). These different findings further reinforce the CTTCCG motif as a 96 strong mutational signature in melanoma. 97
We next investigated whether the observed signature would be relevant also outside of 98 promoter regions. As expected, numerous mutations occurred in CTTCCG sequences across 99 the genome, but notably we found that recurrent mutations involving this motif were always 100 located close to actively transcribed TSSs (Fig. 3abc) . We further compared the frequencies 101 of mutations occurring at cytosines in the context of the motif to all possible trinucleotide 102 contexts, an established way of describing mutational signatures in cancer 8 . As expected, on a 103 genome-wide scale, the mutation probability for cytosines in CTTCCG-related contexts was 104 only marginally higher compared to corresponding trinucleotide contexts ( Fig. 4a) . However, 105 close to TSSs, the signature conferred a striking elevation in mutation probability compared to 106 related trinucleotides, in particular for cytosines at the 5' end of the motif and most notably 107 near highly expressed genes ( Fig. 4b-d ). Recurrent promoter mutations in melanoma thus 108 conform to a distinct sequence signature manifested only in the context active promoters, 109
suggesting that a specific binding partner is required for the element to confer elevated 110 mutation probability. 111 CTTCCG elements have in various individual promoters been shown to be bound by 112 ETS factors such as ETS1, GABPA and ELF1 21 , ELK4 22 , and E4TF1 23 . This suggests that the 113 recurrently mutated CTTCCG elements could be substrates for ETS TFs. As expected, 114 matches to CTTCCG in the JASPAR database of TF binding motifs were mainly ETS-related 115 ( Supplementary Table 6 ). Notably, recurrently mutated CTTCCG sites were evolutionarily 116 conserved to a larger degree than non-recurrently mutated but otherwise similar control sites, 117 further supporting that they constitute functional ETS binding sites ( Supplementary Fig. 2) . 118
This was corroborated by analysis of top recurrent CTTCCG sites in relation to ENCODE 119
ChIP-seq data for 161 TFs, which showed that the strongest and most consistent signals were 120 for ETS factors (GABPA and ELF1) ( Supplementary Fig. 3) . 121
The distribution of mutations across tumor genomes is shaped both by mutagenic and 122 DNA repair processes. Binding of TFs to DNA can increase local mutation rates by impairing 123 NER, and strong increases have been observed in predicted sites for several ETS factors 6, 7 . It 124 is also established that contacts between DNA and proteins can modulate DNA damage 125 patterns by altering conditions for UV photoproduct formation [24] [25] [26] [27] . In upstream regions of 126 XPC -/-cSCC tumors lacking global NER, we found that the CTTCCG signature still 127 conferred strongly elevated mutation probabilities compared to relevant trinucleotide contexts 128 ( Supplementary Fig. 4 ), although to a lesser extent than in melanomas with functional NER 129 ( Fig. 4) . Transcription-coupled NER (TC-NER) may still be active in XPC -/-tumors, and the 130 signature could thus theoretically arise due to inhibition of TC-NER at CTTCCG elements. 131
However, the recurrently mutated positions were typically positioned upstream of the TSSs 132 ( Fig. 1) and should not be subjected to this process. Additionally, TC-NER is strand-specific 14 133 while the mutations occurred independently of strand orientation relative to the downstream 134 gene ( Supplementary Fig. 4 ). The signature described here is thus unlikely explained by 135 impaired NER alone and may instead arise due to inhibition of other repair processes or due 136 to favorable conditions for UV lesion formation at the 5' end of ETS-bound CTTCCG 137 elements. 138
Finally, we sought to experimentally test our proposed model that the observed 139 promoter hotspots are due to localized vulnerability to mutagenesis by UV light. We 140 subjected human melanoma cells and keratinocytes to daily UV doses for a period of 5 or 10 141 weeks ( Fig. 5a ) and used an ultrasensititive error-correcting amplicon sequencing protocol, 142
SiMSen-Seq 28 , to assay two of the observed promoter hotpots for mutations: RPL13A, the 143 most frequently mutated site in the tumor data (Table 1) , and DPH3 10,20 . Between 36k and 144 82k error-corrected reads (>20x oversampling) were obtained for each of 16 different 145 conditions ( Fig. 5b-c) . Strikingly, subclonal mutations appeared specifically in expected 146 positions at both time points and in both cell lines at a frequency reaching up to 2.9% of 147 fragments (RPL13A, 10 weeks of exposure), while being absent in non-exposed control cells 148 ( Fig. 5d-e ). As predicted by the tumor data, mutations occurred primarily at cytosines 149 upstream of the TTCCG motif, with lower-frequency mutations occurring also in the central 150 cytosines. Few mutations were observed outside of the TTCCG context despite presence of 151 many cytosines in theoretically vulnerable configurations in the two amplicons ( Fig. 5d-e , 152 underscored). These results further reinforce that recurrent mutation hotspots in promoters in 153 melanoma arise due to an exceptional vulnerability to UV mutagenesis in these positions. 154
In summary, we demonstrate that recurrent promoter mutations are common in 155 melanoma, but also that they adhere to a distinct sequence signature in a strikingly consistent 156 manner, arguing against positive selection as a major driving force. This model is supported 157 by several additional observations, including lack of cancer-relevant genes, lack of obvious 158 effects on gene expression, presence of the signature exclusively in UV-exposed samples of 159 diverse cellular origins, and strong positive correlation between genome-wide mutation load 160 and mutations in the affected positions. Crucially, exposing cells to UV light under controlled 161 conditions efficiently induces mutations specifically in affected sites. These results point to 162 limitations in conventional genome-wide derived trinucleotide models of mutational 163 signatures, and imply that extended sequence patterns as well as genomic context should be 164 taken into account to improve interpretation of somatic mutations in regulatory DNA. 165
Methods

166
Mapping of somatic mutations 167
Whole-genome sequencing data for 38 skin cutaneous melanoma (SKCM) metastases was 168 obtained from the Cancer Genome Atlas (TCGA) together with matching RNA-seq data. 
RNA-seq data processing 180
RNA-seq data was analyzed with resepect to the GENCODE 31 (v17) annotation using HTSeq-181 count (http://www-huber.embl.de/users/anders/HTSeq) as previously described 34 . Differential 182 gene expression between tumors with and without mutations in promoter regions was 183 evaluated using the two-sided Wilcoxon rank sum test, avoiding assumptions about 184 distribution or directionality. 185
Analyzed genomic regions 186
The SKCM tumors were analyzed across the whole genome or in regions close to TSS, in 187 which case only mutations less than 500 bp upstream or downstream of TSS were included. 188
For the analysis of regions close to TSS the genes were divided in three tiers of equal size 189 based on the mean gene expression level across the 38 SKCM tumors.
Mutation probability calculation 191
The February 2009 assembly of the human genome (hg19/GRCh37) was downloaded from 192 the UCSC Genome Bioinformatics site. Sequence motif and trinucleotide frequencies were 193 obtained using the tool fuzznuc included in the software suite EMBOSS 35 . The mutation 194 probability was calculated as the total number of observed mutations in a given sequence 195 context across all tumors divided by the number of instances of this sequence multiplied by 196 the number of tumors. 197
Evolutionary conservation data 198
The evolutionary conservation of genome regions was evaluated using phastCons scores 36 199 from multiple alignments of 100 vertebrate species retrieved from the UCSC genome 200 browser. The analyzed regions were 30 bases upstream and downstream of the motif 201 CTTCCG located less than 500 bp from TSS. 202
ChIP-seq data 203
Binding of transcription factors at NCTTCCGN sites was evaluated using normalized scores 204 for ChIP-seq peaks from 161 transcription factors in 91 cell types (ENCODE track 205 wgEncodeRegTfbsClusteredV3) obtained from the UCSC genome browser. 206
Analysis of whole genome sequencing data from UV-exposed skin 207
Whole genome sequencing data from sun-exposed skin, eye-lid epidermis, was obtained from 208 Martincorena et al., 2015 19 . Samtools 29 (command mpileup with a minimum mapping quality 209 of 60, a minimum base quality of 30 and additional option -B) was used to process the data 210 and VarScan 30 (command mpileup2snp counting all variants present in at least one read, with 211 minimum coverage of one read and the additional strand filter option disabled) was used for 212 mutation calling. 213 Wilcoxon rank sum test of differential expression of the gene between tumors with and 407 without the mutation. j Distance from mutation to the second closest 5'-most TSS in 408 GENCODE 17, when present within 500 bp. Negative values indicate an upstream location. 409 k Second closest gene. l Same as column h for the second gene, when applicable. m P-values 410 from a two-sided Wilcoxon rank sum test of differential expression of the gene comparing 411 tumors with and without the mutation. n Significant differential expression could not be seen 412 when the analysis was repeated in a larger dataset 10 . 413 melanomas were analyzed for individual recurrently mutated bases in promoter regions, and most highly recurrent positions were found to share a distinct sequence context, CTTCCG (see Table 1 ). CCCTTCCG  GCCTTCCG  TCCTTCCG  ACTTCCG  CCTTCCG  GCTTCCG  TCTTCCG  CTTCCG  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG  TTT   ACCTTCCG  CCCTTCCG  GCCTTCCG  TCCTTCCG  ACTTCCG  CCTTCCG  GCTTCCG  TCTTCCG  CTTCCG  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG  TTT   d   ACCTTCCG  CCCTTCCG  GCCTTCCG  TCCTTCCG  ACTTCCG  CCTTCCG  GCTTCCG  TCTTCCG  CTTCCG  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG  TTT   c   ACCTTCCG  CCCTTCCG  GCCTTCCG  TCCTTCCG  ACTTCCG  CCTTCCG  GCTTCCG  TCTTCCG  CTTCCG  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG PhastCons conservation scores at CTTCCG sites in melanoma promoter hotspot sites (a) and in 24 randomly chosen CTTCCG sites less than 500 bp from TSS of highly expressed genes, that were not mutated in any tumor (b). PhastCons conservation scores were derived from multiple alignments of 100 vertebrate species and downloaded from the UCSC genome browser. POLR2A  ELF1  GABPA  PHF8  TAF1  MAX  YY1  MAZ  TBP  EGR1  MYC  E2F1  CTCF  RUNX3  E2F6  CHD2  MXI1  PML  JUND  SIN3AK20  ZBTB7A  REST  SIN3A  IRF1  ZNF263  SIX5  E2F4  ELK1  ETS1  SRF  KDM5B  ELK4  RBBP5  ZNF143  POU2F2  EP300  CCNT2  NFIC  CREB1 GABPA  ELF1  TAF1  MAX  PHF8  YY1  PML  MYC  TBP  MXI1  EGR1  RUNX3  MAZ  CHD2  E2F1  ELK1  SIN3A  SP1  REST  IRF1  E2F4  RBBP5  ZNF143  CREB1  E2F6  ETS1  KDM5B  SIN3AK20  JUND  SIX5  SRF  CTCF  POU2F2  NFYB  USF1  ELK4  RELA  NRF1 Only upstream regions were considered to avoid influence from transcription-coupled repair. The assignment to template and non-template strands was determined by the transcription direction of the downstream gene. Notably, transcription coupled repair is a strand-specific process, but elevated probabilities for CTTCCG-related context compared to trinucleotides were observed regardless of the strand orientation. Mutation probability × 10 -3   ACCTTCCG  CCCTTCCG  GCCTTCCG  TCCTTCCG  ACTTCCG  CCTTCCG  GCTTCCG  TCTTCCG  CTTCCG  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG  TTT   ACCTTCCG  CCCTTCCG  GCCTTCCG  TCCTTCCG  ACTTCCG  CCTTCCG  GCTTCCG  TCTTCCG  CTTCCG  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG 
Analysis of whole genome sequencing data from cSCC tumors
- - - - - - - - 0 0.18 ASXL2 chr2:26101489 - - - - - (0.05) - (0.038) 0 0.13 PDCD11 chr10:105156316 - - - - - - - - 0 0.13 FTH1 chr11:61735192 - - - - - - - - 0 0.13 FTH1 chr11:61735191 - - - - - - - - 0 0.13 FUBP3 chr9:133454938 - - - - - - - - 0 0.13 ALYREF chr17:79849513 - - - - - - - - 0 0.13 RNF185 chr22:31556121 - - - - - - (0.053) - 0 0.13 MRPS31 chr13:41345346 - - - - - (0.033) - (0.028) 0 0.13 DPH3 chr3:16306505 - - - - - - - (0.03) 0 0.13 RPL18A chr19:17970682 - - - - (0.12) - (0.12) - 0 0.13 C16orf59 chr16:2510096 - - - - - - (0.071) - 0 0.13 DERL1 chr8:124054557 - - - - - - - - 0 0.13 MASTL chr10:27443328 - - - - - - - - 0 0.11 DIXDC1 chr11:111797698 - - - - - - - - 0 0.11 SMUG1 chr12:54582890 - - - - - - - 0.23 0.12 0.11 SMUG1 chr12:54582889 - - - - - - - - 0 0.11 CDC20 chr1:43824529 - - - - - - - (0.034) 0 0.11
